About Envy Medical, Inc.
Envy’s mission is to offer highly effective noninvasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel™, a breakthrough system that combines precision non-invasive exfoliation with Dermalinfusion™, for a deep delivery of a diverse set of skin-specific solutions, for better outcomes in treating acne, hyperpigmentation, scars, fine lines and wrinkles. The Company also owns exclusive rights to Lumixyl™. Developed by Dr. Basil Hantash’s team of dermatological researchers out of Stanford University, this ground-breaking technology is the only peptide clinically shown to significantly brighten skin, and address hyper-pigmentation. Recent studies show that Lumixyl™, a chain of ten amino acids, addresses hyper-pigmentation more efficaciously than hydroquinone - the most commonly prescribed medication for the treatment of hyperpigmentation. Envy is currently developing a rich portfolio
Envy Medical, Inc. Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X